HMGB1 and atherosclerosis: Interesting data suggests that in ApoE-/-mice, monoclonal anti-HMGB1 neutralizing antibodies reduced atherosclerosis, macrophages, smooth muscle and dendritic cell accumulations, and they reduced vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression [21].